{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T10:47:01Z","timestamp":1756464421834},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurosci. Bull."],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1007\/s12264-016-0038-5","type":"journal-article","created":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T03:56:31Z","timestamp":1464753391000},"page":"463-468","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Blood Biomarkers in Minor Stroke and Transient Ischemic Attack"],"prefix":"10.1007","volume":"32","author":[{"given":"Jiejie","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongjun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,6,1]]},"reference":[{"key":"38_CR1","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1161\/STROKEAHA.107.502807","volume":"39","author":"D Zhao","year":"2008","unstructured":"Zhao D, Liu J, Wang W, Zeng Z, Cheng J, Liu J, et al. Epidemiological transition of stroke in China: twenty-one-year observational study from the Sino-MONICA-Beijing Project. Stroke 2008, 39: 1668\u20131674.","journal-title":"Stroke"},{"key":"38_CR2","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1747-4949.2007.00142.x","volume":"2","author":"YL Wang","year":"2007","unstructured":"Wang YL, Wu D, Liao X, Zhang W, Zhao X, Wang YJ. Burden of stroke in China. Int J Stroke 2007, 2: 211\u2013213.","journal-title":"Int J Stroke"},{"key":"38_CR3","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1212\/WNL.0000000000001665","volume":"84","author":"Y Wang","year":"2015","unstructured":"Wang Y, Zhao X, Jiang Y, Li H, Wang L, Johnston SC, et al. Prevalence, knowledge, and treatment of transient ischemic attacks in China. Neurology 2015, 84: 2354\u20132361.","journal-title":"Neurology"},{"key":"38_CR4","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/S0140-6736(07)61448-2","volume":"370","author":"PM Rothwell","year":"2007","unstructured":"Rothwell PM, Giles MF, Chandratheva A, Marquardt L, Geraghty O, Redgrave JN, et al. Effect of urgent treatment of transient ischaemic attack and minor stroke on early recurrent stroke (EXPRESS study): a prospective population-based sequential comparison. Lancet 2007, 370: 1432\u20131442.","journal-title":"Lancet"},{"key":"38_CR5","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1161\/STROKEAHA.109.577650","volume":"41","author":"J Castle","year":"2010","unstructured":"Castle J, Mlynash M, Lee K, Caulfield AF, Wolford C, Kemp S, et al. Agreement regarding diagnosis of transient ischemic attack fairly low among stroke-trained neurologists. Stroke 2010, 41: 1367\u20131370.","journal-title":"Stroke"},{"key":"38_CR6","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1159\/000166839","volume":"26","author":"S Prabhakaran","year":"2008","unstructured":"Prabhakaran S, Silver AJ, Warrior L, McClenathan B, Lee VH. Misdiagnosis of transient ischemic attacks in the emergency room. Cerebrovasc Dis 2008, 26: 630\u2013635.","journal-title":"Cerebrovasc Dis"},{"key":"38_CR7","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0140-6736(07)60151-2","volume":"369","author":"JA Chalela","year":"2007","unstructured":"Chalela JA, Kidwell CS, Nentwich LM, Luby M, Butman JA, Demchuk AM, et al. Magnetic resonance imaging and computed tomography in emergency assessment of patients with suspected acute stroke: a prospective comparison. Lancet 2007, 369: 293\u2013298.","journal-title":"Lancet"},{"key":"38_CR8","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1161\/01.STR.0000158917.59233.b7","volume":"36","author":"D Kleindorfer","year":"2005","unstructured":"Kleindorfer D, Panagos P, Pancioli A, Khoury J, Kissela B, Woo D, et al. Incidence and short-term prognosis of transient ischemic attack in a population-based study. Stroke 2005, 36: 720\u2013723.","journal-title":"Stroke"},{"key":"38_CR9","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1136\/bmj.37991.635266.44","volume":"328","author":"AJ Coull","year":"2004","unstructured":"Coull AJ, Lovett JK, Rothwell PM, Oxford Vascular S. Population based study of early risk of stroke after transient ischaemic attack or minor stroke: implications for public education and organisation of services. BMJ 2004, 328: 326.","journal-title":"BMJ"},{"key":"38_CR10","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1001\/jama.284.22.2901","volume":"284","author":"SC Johnston","year":"2000","unstructured":"Johnston SC, Gress DR, Browner WS, Sidney S. Short-term prognosis after emergency department diagnosis of TIA. JAMA 2000, 284: 2901\u20132906.","journal-title":"JAMA"},{"key":"38_CR11","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1212\/01.WNL.0000110311.09970.83","volume":"62","author":"JK Lovett","year":"2004","unstructured":"Lovett JK, Coull AJ, Rothwell PM. Early risk of recurrence by subtype of ischemic stroke in population-based incidence studies. Neurology 2004, 62: 569\u2013573.","journal-title":"Neurology"},{"key":"38_CR12","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1056\/NEJMoa1412981","volume":"374","author":"P Amarenco","year":"2016","unstructured":"Amarenco P, Lavallee PC, Labreuche J, Albers GW, Bornstein NM, Canhao P, et al. One-Year Risk of Stroke after Transient Ischemic Attack or Minor Stroke. N Engl J Med 2016, 374: 1533\u20131542.","journal-title":"N Engl J Med"},{"key":"38_CR13","first-page":"891","volume":"48","author":"HS Jorgensen","year":"1997","unstructured":"Jorgensen HS, Nakayama H, Reith J, Raaschou HO, Olsen TS. Stroke recurrence: predictors, severity, and prognosis. The Copenhagen Stroke Study. Neurology 1997, 48: 891\u2013895.","journal-title":"The Copenhagen Stroke Study. Neurology"},{"key":"38_CR14","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3109\/07853890903260898","volume":"42","author":"CJ Pepine","year":"2010","unstructured":"Pepine CJ. Residual risk for secondary ischemic events in patients with atherothrombotic disease: opportunity for future improvements in patient care. Ann Med 2010, 42: 19\u201335.","journal-title":"Ann Med"},{"key":"38_CR15","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s11239-007-0083-z","volume":"26","author":"O Onalan","year":"2008","unstructured":"Onalan O, Balta G, Oto A, Kabakci G, Tokgozoglu L, Aytemir K, et al. Plasminogen activator inhibitor-1 4G4G genotype is associated with myocardial infarction but not with stable coronary artery disease. J Thromb Thrombolysis 2008, 26: 211\u2013217.","journal-title":"J Thromb Thrombolysis"},{"key":"38_CR16","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s11239-009-0398-z","volume":"29","author":"LS Rallidis","year":"2010","unstructured":"Rallidis LS, Gialeraki A, Merkouri E, Liakos G, Dagres N, Sionis D, et al. Reduced carriership of 4G allele of plasminogen activator inhibitor-1 4G\/5G polymorphism in very young survivors of myocardial infarction. J Thromb Thrombolysis 2010, 29: 497\u2013502.","journal-title":"J Thromb Thrombolysis"},{"key":"38_CR17","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1046\/j.1365-2141.2000.02164.x","volume":"110","author":"G Endler","year":"2000","unstructured":"Endler G, Lalouschek W, Exner M, Mitterbauer G, Haring D, Mannhalter C. The 4G\/4G genotype at nucleotide position -675 in the promotor region of the PAI-1 gene is less frequent in young patients with minor stroke than in controls. Br J Haematol 2000, 110: 469\u2013471.","journal-title":"Br J Haematol"},{"key":"38_CR18","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S1474-4422(10)70083-1","volume":"9","author":"PF Chinnery","year":"2010","unstructured":"Chinnery PF, Elliott HR, Syed A, Rothwell PM. Mitochondrial DNA haplogroups and risk of transient ischaemic attack and ischaemic stroke: a genetic association study. Lancet Neurol 2010, 9: 498\u2013503.","journal-title":"Lancet Neurol"},{"key":"38_CR19","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0049-3848(98)00154-6","volume":"93","author":"W Lalouschek","year":"1999","unstructured":"Lalouschek W, Aull S, Serles W, Schnider P, Mannhalter C, Pabinger-Fasching I, et al. C677T MTHFR mutation and factor V Leiden mutation in patients with TIA\/minor stroke: a case-control study. Thromb Res 1999, 93: 61\u201369.","journal-title":"Thromb Res"},{"key":"38_CR20","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1111\/ijs.12293","volume":"10","author":"PM George","year":"2015","unstructured":"George PM, Mlynash M, Adams CM, Kuo CJ, Albers GW, Olivot JM. Novel TIA biomarkers identified by mass spectrometry-based proteomics. Int J Stroke 2015, 10: 1204\u20131211.","journal-title":"Int J Stroke"},{"key":"38_CR21","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1161\/01.STR.0000121646.23955.0f","volume":"35","author":"UG Schulz","year":"2004","unstructured":"Schulz UG, Flossmann E, Rothwell PM. Heritability of ischemic stroke in relation to age, vascular risk factors, and subtypes of incident stroke in population-based studies. Stroke 2004, 35: 819\u2013824.","journal-title":"Stroke"},{"key":"38_CR22","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/00019052-200102000-00015","volume":"14","author":"GJ Hankey","year":"2001","unstructured":"Hankey GJ, Eikelboom JW. Homocysteine and stroke. Curr Opin Neurol 2001, 14: 95\u2013102.","journal-title":"Curr Opin Neurol"},{"key":"38_CR23","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1161\/01.STR.31.5.1069","volume":"31","author":"JW Eikelboom","year":"2000","unstructured":"Eikelboom JW, Hankey GJ, Anand SS, Lofthouse E, Staples N, Baker RI. Association between high homocyst(e)ine and ischemic stroke due to large- and small-artery disease but not other etiologic subtypes of ischemic stroke. Stroke 2000, 31: 1069\u20131075.","journal-title":"Stroke"},{"key":"38_CR24","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1161\/STROKEAHA.107.513416","volume":"39","author":"U Khan","year":"2008","unstructured":"Khan U, Crossley C, Kalra L, Rudd A, Wolfe CD, Collinson P, et al. Homocysteine and its relationship to stroke subtypes in a UK black population: the south London ethnicity and stroke study. Stroke 2008, 39: 2943\u20132949.","journal-title":"Stroke"},{"key":"38_CR25","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1179\/016164109X12445616596445","volume":"32","author":"Y Ma","year":"2010","unstructured":"Ma Y, Zhao X, Zhang W, Liu L, Wang Y, Fang R. Homocysteine and ischemic stroke subtype: a relationship study in Chinese patients. Neurol Res 2010, 32: 636\u2013641.","journal-title":"Neurol Res"},{"key":"38_CR26","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1038\/nm.1870","volume":"14","author":"RL Wilensky","year":"2008","unstructured":"Wilensky RL, Shi Y, Mohler ER, 3rd, Hamamdzic D, Burgert ME, Li J, et al. Inhibition of lipoprotein-associated phospholipase A2 reduces complex coronary atherosclerotic plaque development. Nat Med 2008, 14: 1059\u20131066.","journal-title":"Nat Med"},{"key":"38_CR27","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1161\/hh2401.101272","volume":"89","author":"U Schonbeck","year":"2001","unstructured":"Schonbeck U, Libby P. CD40 signaling and plaque instability. Circ Res 2001, 89: 1092\u20131103.","journal-title":"Circ Res"},{"key":"38_CR28","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1215340","volume":"369","author":"Y Wang","year":"2013","unstructured":"Wang Y, Zhao X, Liu L, Wang D, Wang C, Li H, et al. Clopidogrel with aspirin in acute minor stroke or transient ischemic attack. N Engl J Med 2013, 369: 11\u201319.","journal-title":"N Engl J Med"},{"key":"38_CR29","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1212\/WNL.0000000000001938","volume":"85","author":"J Lin","year":"2015","unstructured":"Lin J, Zheng H, Cucchiara BL, Li J, Zhao X, Liang X, et al. Association of Lp-PLA2-A and early recurrence of vascular events after TIA and minor stroke. Neurology 2015, 85: 1585\u20131591.","journal-title":"Neurology"},{"key":"38_CR30","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1161\/STROKEAHA.115.008685","volume":"46","author":"J Li","year":"2015","unstructured":"Li J, Wang Y, Lin J, Wang D, Wang A, Zhao X, et al. Soluble CD40L Is a Useful Marker to Predict Future Strokes in Patients With Minor Stroke and Transient Ischemic Attack. Stroke 2015, 46: 1990\u20131992.","journal-title":"Stroke"},{"key":"38_CR31","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1600-0404.2006.00715.x","volume":"115","author":"F Purroy","year":"2007","unstructured":"Purroy F, Montaner J, Molina CA, Delgado P, Arenillas JF, Chacon P, et al. C-reactive protein predicts further ischemic events in transient ischemic attack patients. Acta Neurol Scand 2007, 115: 60\u201366.","journal-title":"Acta Neurol Scand"},{"key":"38_CR32","doi-asserted-by":"crossref","first-page":"850714","DOI":"10.1155\/2013\/850714","volume":"2013","author":"X Gong","year":"2013","unstructured":"Gong X, Zou X, Liu L, Pu Y, Wang Y, Pan Y, et al. Prognostic value of inflammatory mediators in 1-year outcome of acute ischemic stroke with middle cerebral artery stenosis. Mediators Inflamm 2013, 2013: 850714.","journal-title":"Mediators Inflamm"},{"key":"38_CR33","doi-asserted-by":"crossref","first-page":"c2541","DOI":"10.1136\/bmj.c2541","volume":"340","author":"D Cohen","year":"2010","unstructured":"Cohen D, Berger SP, Steup-Beekman GM, Bloemenkamp KW, Bajema IM. Diagnosis and management of the antiphospholipid syndrome. BMJ 2010, 340: c2541.","journal-title":"BMJ"},{"key":"38_CR34","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1161\/01.STR.32.8.1701","volume":"32","author":"RL Brey","year":"2001","unstructured":"Brey RL, Abbott RD, Curb JD, Sharp DS, Ross GW, Stallworth CL, et al. beta(2)-Glycoprotein 1-dependent anticardiolipin antibodies and risk of ischemic stroke and myocardial infarction: the honolulu heart program. Stroke 2001, 32: 1701\u20131706.","journal-title":"Stroke"},{"key":"38_CR35","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3389\/fneur.2012.00137","volume":"3","author":"MT Mullen","year":"2012","unstructured":"Mullen MT, Messe SR, Kasner SE, Sansing L, Husain MR, Norman GL, et al. Anti-Phosphatidylserine-Prothrombin Antibodies are Associated with Outcome in a TIA Cohort. Front Neurol 2012, 3: 137.","journal-title":"Front Neurol"},{"key":"38_CR36","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1161\/STROKEAHA.114.007624","volume":"46","author":"S Greisenegger","year":"2015","unstructured":"Greisenegger S, Segal HC, Burgess AI, Poole DL, Mehta Z, Rothwell PM. Biomarkers and mortality after transient ischemic attack and minor ischemic stroke: population-based study. Stroke 2015, 46: 659\u2013666.","journal-title":"Stroke"},{"key":"38_CR37","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1016\/j.jacc.2011.08.057","volume":"58","author":"DW Park","year":"2011","unstructured":"Park DW, Lee SW, Yun SC, Song HG, Ahn JM, Lee JY, et al. A point-of-care platelet function assay and C-reactive protein for prediction of major cardiovascular events after drug-eluting stent implantation. J Am Coll Cardiol 2011, 58: 2630\u20132639.","journal-title":"J Am Coll Cardiol"},{"key":"38_CR38","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1161\/CIRCULATIONAHA.109.876763","volume":"120","author":"DW Park","year":"2009","unstructured":"Park DW, Yun SC, Lee JY, Kim WJ, Kang SJ, Lee SW, et al. C-reactive protein and the risk of stent thrombosis and cardiovascular events after drug-eluting stent implantation. Circulation 2009, 120: 1987\u20131995.","journal-title":"Circulation"},{"key":"38_CR39","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1177\/0003319711406432","volume":"63","author":"H Ge","year":"2012","unstructured":"Ge H, Zhou Y, Liu X, Nie X, Wang Z, Guo Y, et al. Relationship between plasma inflammatory markers and platelet aggregation in patients with clopidogrel resistance after angioplasty. Angiology 2012, 63: 62\u201366.","journal-title":"Angiology"},{"key":"38_CR40","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1056\/NEJMoa022600","volume":"348","author":"C Heeschen","year":"2003","unstructured":"Heeschen C, Dimmeler S, Hamm CW, van den Brand MJ, Boersma E, Zeiher AM, et al. Soluble CD40 ligand in acute coronary syndromes. N Engl J Med 2003, 348: 1104\u20131111.","journal-title":"N Engl J Med"},{"key":"38_CR41","doi-asserted-by":"crossref","first-page":"559","DOI":"10.2165\/00002512-200623070-00002","volume":"23","author":"G Feher","year":"2006","unstructured":"Feher G, Koltai K, Papp E, Alkonyi B, Solyom A, Kenyeres P, et al. Aspirin resistance: possible roles of cardiovascular risk factors, previous disease history, concomitant medications and haemorrheological variables. Drugs Aging 2006, 23: 559\u2013567.","journal-title":"Drugs Aging"},{"key":"38_CR42","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1586\/ern.10.203","volume":"11","author":"MA Topcuoglu","year":"2011","unstructured":"Topcuoglu MA, Arsava EM, Ay H. Antiplatelet resistance in stroke. Expert Rev Neurother 2011, 11: 251\u2013263.","journal-title":"Expert Rev Neurother"},{"key":"38_CR43","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.jcma.2012.07.005","volume":"75","author":"PT Lai","year":"2012","unstructured":"Lai PT, Chen SY, Lee YS, Ho YP, Chiang YY, Hsu HY. Relationship between acute stroke outcome, aspirin resistance, and humoral factors. J Chin Med Assoc 2012, 75: 513\u2013518.","journal-title":"J Chin Med Assoc"},{"key":"38_CR44","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1212\/WNL.0000000000001421","volume":"84","author":"J Li","year":"2015","unstructured":"Li J, Wang Y, Wang D, Lin J, Wang A, Zhao X, et al. Glycated albumin predicts the effect of dual and single antiplatelet therapy on recurrent stroke. Neurology 2015, 84: 1330\u20131336.","journal-title":"Neurology"},{"key":"38_CR45","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1212\/WNL.0000000000001431","volume":"84","author":"GC Jickling","year":"2015","unstructured":"Jickling GC. Comment: TIA response to antiplatelets stratified by glycated albumin. Neurology 2015, 84: 1334.","journal-title":"Neurology"},{"key":"38_CR46","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1161\/STROKEAHA.109.572883","volume":"41","author":"U Fischer","year":"2010","unstructured":"Fischer U, Baumgartner A, Arnold M, Nedeltchev K, Gralla J, De Marchis GM, et al. What is a minor stroke? Stroke 2010, 41: 661\u2013666.","journal-title":"Stroke"},{"key":"38_CR47","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1161\/STROKEAHA.113.001857","volume":"44","author":"JF Meschia","year":"2013","unstructured":"Meschia JF, Arnett DK, Ay H, Brown RD, Jr., Benavente OR, Cole JW, et al. Stroke Genetics Network (SiGN) study: design and rationale for a genome-wide association study of ischemic stroke subtypes. Stroke 2013, 44: 2694\u20132702.","journal-title":"Stroke"},{"key":"38_CR48","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1093\/hmg\/ddu559","volume":"24","author":"AM Gomez-Uriz","year":"2015","unstructured":"Gomez-Uriz AM, Milagro FI, Mansego ML, Cordero P, Abete I, De Arce A, et al. Obesity and ischemic stroke modulate the methylation levels of KCNQ1 in white blood cells. Hum Mol Genet 2015, 24: 1432\u20131440.","journal-title":"Hum Mol Genet"}],"container-title":["Neuroscience Bulletin"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12264-016-0038-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12264-016-0038-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12264-016-0038-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T11:28:48Z","timestamp":1498303728000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12264-016-0038-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,1]]},"references-count":48,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["38"],"URL":"https:\/\/doi.org\/10.1007\/s12264-016-0038-5","relation":{},"ISSN":["1673-7067","1995-8218"],"issn-type":[{"value":"1673-7067","type":"print"},{"value":"1995-8218","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,1]]}}}